NAION is a form of sudden vision loss caused by reduced blood flow to the optic nerve. A possible association with semaglutide has been investigated and the evidence has developed over time. It is rare. The practical response is straightforward: sudden vision loss or change in one eye is an emergency regardless of cause.
Seek emergency eye care immediately for:
- Sudden loss of vision, or a sudden change in vision, in one or both eyes
- A dark area or shadow in part of your visual field, often the upper or lower half
- Sudden blurring that does not clear
- Vision loss with eye pain, or with headache and scalp tenderness
Do not wait to see whether it improves overnight. With optic nerve problems, time matters.
For how this fits alongside the other effects of these medications, see GLP-1 Side Effects: The Complete Management Guide.
What NAION is
Non-arteritic anterior ischaemic optic neuropathy: the blood supply to the front of the optic nerve is reduced, and the nerve is damaged. It typically causes painless vision loss in one eye, often noticed on waking, and frequently affects part of the visual field rather than all of it.
It is uncommon in the general population, and vision loss from it is often permanent, which is why it attracts attention out of proportion to its frequency.
Established risk factors include diabetes, high blood pressure, sleep apnea, and a particular optic disc anatomy sometimes described as a crowded disc.
The association, honestly
A possible link with semaglutide was raised by observational research and has since been examined further, including by regulators. Product labelling and regulatory positions have developed as that work progressed.
Two things make this genuinely difficult to interpret. The people taking these medications already carry several NAION risk factors, particularly diabetes and sleep apnea, so separating the drug from the population is hard. And NAION is rare enough that even a real increase in risk translates to a very small absolute number of cases.
Because this area has moved, check the current prescribing information and current regulatory guidance rather than relying on a summary, including this one.
The separate issue: diabetic retinopathy
This is a different matter and gets conflated with NAION constantly.
In people with type 2 diabetes and existing retinopathy, rapid improvement in blood sugar has been associated with temporary worsening of retinopathy. This is a recognised phenomenon that predates GLP-1 medications and relates to the speed of glucose improvement rather than to any specific drug.
If you have diabetes with existing eye disease, tell your prescriber before starting. Eye monitoring may be recommended, and the pace of glucose improvement may be managed differently.
What to do practically
Tell your prescriber if you have diabetes, existing eye disease, sleep apnea, or have had NAION before. That last one particularly, since a previous episode in one eye raises the risk in the other.
Keep up routine eye checks, which matter for anyone with diabetes regardless of this question.
Know the emergency symptoms, and act on them the same day rather than waiting for an optician appointment.
Diabetic retinopathy is a separate issue that gets conflated with this, and it relates to the speed of glucose improvement rather than the drug. Sudden vision change is on the emergency list in symptoms that mean stop immediately.
Frequently asked questions
Should I stop taking it over this?
That is a decision for your prescriber, weighing a rare risk against the benefit you are getting. Do not stop unilaterally.
How likely is it?
NAION is rare. Ask your prescriber to discuss the current evidence against your own risk factors.
Does it affect both eyes?
Usually one at a time. A previous episode raises the risk to the other eye.
Is blurry vision a warning sign?
Transient blurring can accompany blood sugar changes. Sudden persistent change, or a shadow in your field, needs emergency assessment.
Does this apply to tirzepatide?
Labelling is product-specific. Check the current prescribing information for what you take.
Should I see an ophthalmologist before starting?
Not routinely, unless you have diabetes with eye disease or a history that warrants it. Ask your prescriber.